Axtria Unveils Transformational Agentic AI Platform to Help Life Sciences Companies Deploy, Scale, and Monetize Innovation

USA - English

• India - English

Axtria InsightsMAx.ai Delivers an Enterprise-Grade Flexible Framework with 30+ Ready-to-Deploy Agents, Apps, and APIs

BERKELEY HEIGHTS, N.J., April 23, 2025 /PRNewswire/ -- Axtria Inc., an AI-first data analytics innovator transforming life sciences, today announced its next generation of Axtria InsightsMAx™. Powered by agentic AI, the new Axtria InsightsMAx.ai fundamentally reimagines how life sciences organizations harness artificial intelligence through a flexible enterprise-grade platform that accelerates experimentation, deployment, and ROI.

"Axtria InsightsMAx.ai represents a paradigm shift from incremental AI improvements to true business transformation," said Lokesh Jindal, Head of Products at Axtria. "Axtria InsightsMAx.ai serves as essential infrastructure—the plumbing, if you will—that makes agentic AI implementation practical, scalable, and measurable. While others focus on isolated use cases, we've built the interconnected system that enables life sciences companies to rapidly test, deploy, and scale AI innovation across their entire value chain."

Axtria InsightsMAx.ai solves the critical "last mile" problem in enterprise AI implementation by providing not just the technology, but the entire ecosystem needed for successful adoption. The platform's library of specialized life sciences agents creates an adaptable framework that breaks down silos between data analysis, business intelligence, commercial operations, and clinical development, enabling cross-functional transformation that drives tangible business outcomes.

"What sets our platform apart is its ability to serve as both the experimental sandbox and the production highway for agentic AI," said Navdeep Chadha, Chief Technology Officer at Axtria. "Life sciences companies can start small, proving value in controlled environments, then seamlessly scale successful innovations across their organization without rebuilding infrastructure. This dramatically compresses the time from concept to enterprise-wide deployment from years to months or even weeks."

Enterprise-Grade AI Infrastructure: The Foundation for Pharmaceutical Transformation

Axtria InsightsMAx.ai provides a complete ecosystem for agentic AI implementation through three interconnected offerings:

• Agents: Over 30 domain-specific autonomous agents designed expressly for life sciences workflows are ready for immediate deployment. These agents don't just automate tasks, they transform entire processes by intelligently orchestrating workflows, predicting outcomes, and continuously improving performance through domain-specific learning.
• Apps: Pre-built applications with intuitive interfaces enable business users across the organization to leverage AI capabilities without technical expertise. These apps integrate seamlessly with existing systems, allowing companies to enhance current investments rather than replace them.
• APIs: Enterprise-grade APIs with pharmaceutical-specific data models and compliance controls enable developers to rapidly build custom solutions while maintaining regulatory compliance. This creates an extensible platform that evolves with emerging business needs.

The Experimentation-to-Production Pipeline: Accelerating Innovation at Scale

For organizations seeking to build their innovation roadmap, Axtria InsightsMAx.ai provides a comprehensive development environment that transforms how companies move from concept to enterprise deployment:

• Rapid Experimentation: The no-code interface enables cross-functional teams to prototype AI solutions in days rather than months, with built-in guardrails that ensure compliance and data integrity throughout the process.
• Model Context Protocol Standards: Model Context Protocol (MCP) to standardize agent access to external data, tools, and services which enables seamless integration and empowers agents to act intelligently across real-world pharma contexts.
• Agent Orchestration: Moving beyond single-purpose AI, the platform enables organizations to create complex agent networks that collaborate across functions, breaking down silos and creating end-to-end process transformation.
• Enterprise Deployment Framework: Once validated, solutions can be deployed across global operations with enterprise-grade security, governance, and scalability, eliminating the "pilot purgatory" that plagues many innovation initiatives.
• Continuous Optimization: Built-in monitoring and feedback loops ensure AI solutions evolve with changing business needs and regulatory requirements, maximizing long-term ROI.

Delivering Transformational Business Impact

Axtria InsightsMAx.ai is already revolutionizing operations at six of the top ten global pharmaceutical companies, delivering measurable business outcomes that far exceed traditional AI implementations:

• 90%+ decision accuracy
• 75%+ increase in speed to insights
• 40% reduction in operational costs
• 10X faster onboarding of new products, markets, and teams

Built on Unmatched Domain Expertise and Technological Innovation

Axtria InsightsMAx.ai leverages 14+ years of pharmaceutical-specific data science expertise and proprietary semantic models that understand the nuanced relationships in life sciences data. The platform is powered by domain-tuned large language models (LLMs) developed in partnership with Genloop, delivering superior performance with enhanced control and transparency.

"The pharmaceutical industry faces unique challenges that generic AI solutions simply cannot address effectively," added Chadha. "Our platform combines deep domain knowledge with cutting-edge AI capabilities, creating a purpose-built system that understands the complex interplay of scientific, commercial, and regulatory factors that drive life sciences business transformation."

About Axtria's Products and Solutions

Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx.ai is our agentic platform, featuring more than 30 agents, apps, and APIs, along with a full experimentation environment to find the perfect solution for unique business challenges. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration. 

About Axtria

Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.

SOURCE Axtria, Inc.